scholarly journals Update on Prostate Cancer Diagnosis, Prognosis, and Prediction to Response to Therapy

Cells ◽  
2020 ◽  
Vol 10 (1) ◽  
pp. 20
Author(s):  
Rodolfo Montironi ◽  
Alessia Cimadamore ◽  
Antonio Lopez-Beltran ◽  
Liang Cheng ◽  
Marina Scarpelli

The wide range of novelties reported in this Special Issue of the journal Cells on prostate cancer (PCa) diagnosis, prognosis, and prediction to response to therapy, has led us to a series of considerations related to a better understanding of the current and future role of effective molecular biomarkers in individual patients with PCa [...]

2009 ◽  
Vol 181 (2) ◽  
pp. 594-600 ◽  
Author(s):  
Alberto A. Antunes ◽  
Kátia R. Leite ◽  
Juliana M. Sousa-Canavez ◽  
Luiz H. Camara-Lopes ◽  
Miguel Srougi

2008 ◽  
Vol 179 (4S) ◽  
pp. 684-684
Author(s):  
Alberto A Antunes ◽  
Katia R Leite ◽  
Juliana M Sousa-Canavez ◽  
Luiz H Camara-Lopes ◽  
Miguel Srougi

2020 ◽  
Vol 104 (9-10) ◽  
pp. 731-740
Author(s):  
Matthias Saar ◽  
Johannes Linxweiler ◽  
Angelika Borkowetz ◽  
Sebastian Fussek ◽  
Katerina Urbanova ◽  
...  

2021 ◽  
Vol 17 (2) ◽  
pp. 157-167
Author(s):  
V. S. Petov ◽  
A. V. Sapelko ◽  
S. P. Danilov ◽  
Ya. N. Chernov ◽  
M. S. Taratkin ◽  
...  

The current prostate cancer screening program results in unnecessary biopsies in a quarter of patients, overdiagnosis of clinically insignificant prostate cancer (ISUP 1) and overtreatment. Intoducing multiparametric magnetic resonance imaging into routine practice before biopsy allows to decrease the number of biopsies, thereby reducing the burden on clinicians and increasing the likelihood of detecting clinically significant forms of prostate cancer (ISUP >2).  The objective of this literature review is to compare targeted biopsy techniques and to determine their current role in the prostate cancer diagnosis.


Sign in / Sign up

Export Citation Format

Share Document